₹ 3,190.15 Cr
1.91%
BSE Healthcare TRI
INF740KA1LE6
100.0
100.0
100
Mr. Chirag Dagli
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
DSP Healthcare Fund - Regular Plan - IDCW | 5.48 | 23.34 | 18.54 |
Benchmark | - | - | - |
Equity
Debt
Others
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved
Company | Holdings (%) |
---|---|
CIPLA LIMITED EQ NEW FV RS.2/- | 8.73 |
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 8.22 |
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 7.84 |
SUVEN PHARMACEUTICALS LIMITED EQ | 7.79 |
LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 6.08 |
GLAND PHARMA LIMITED EQ NEW FV Re.1/- | 5.96 |
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 4.58 |
Illumina Inc | 4.52 |
ALEMBIC PHARMACEUTICALS LIMITED EQ | 4.38 |
Sai Life Sciences Limited | 4.32 |
Sector | Holdings (%) |
---|---|
Healthcare | 83.51 |
Financial Services | 1.46 |
Consumer Services | 0.56 |
Scheme Name | 5Y (%) |
---|---|
DSP Healthcare Reg IDCW | 18.54 |
WhiteOak Capital Pharma and Heathcare Fund Reg Plan Gr | 0.0 |
HDFC Pharma and Healthcare Fund Gr | 0.0 |
UTI Healthcare Reg Gr | 18.83 |
SBI HEALTHCARE Opportunities Reg Gr | 20.22 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 21.41 |
LIC MF Healthcare Fund Reg Gr | 14.51 |
Kotak Healthcare Reg Gr | 0.0 |
DSP Healthcare Reg Gr | 19.51 |
Mirae Asset Healthcare Reg Gr | 18.74 |